EVER Neuro Pharma (Austria)

Recent papers from EVER Neuro Pharma (Austria)

1. Low Analytical Evaluation Threshold in Leachables Screening: Challenges, Potential Solutions and Alternative ApproachesPharmaceutical Research · 2026
2. Comparison of Relapse Risk Prediction Models During Active Surveillance in Stage I Seminoma: A Retrospective Multicenter Cohort StudyInternational Journal of Cancer · 2026
3. The Lehto Emergent Gravity (LEG) Framework: A Discrete Causal Derivation of the Standard Model and General Relativity2026
4. The Nature and Treatment of Dividends Under the Entity Concept.The Accounting Review · 1960
5. Separation of Fixed and Variable Costs.The Accounting Review · 1960
6. N-Pep-12 Improves Hippocampal Cognitive Function and Increases Neuroplasticity and Neurogenesis MarkersJournal of Dietary Supplements · 2025
7. Stem-Cell-Assisted Lipotransfer and Platelet-Rich Plasma in Breast Reconstruction: A Literature ReviewAesthetic Plastic Surgery · 2025
8. N-Pep-Zn Improves Cognitive Functions and Acute Stress Response Affected by Chronic Social Isolation in Aged Spontaneously Hypertensive Rats (SHRs)Biomedicines · 2024
9. A Novel Transmembrane CXCR4 Variant That Expands the WHIM Genotype-Phenotype ParadigmBlood Advances · 2024
10. Treatment with Cerebrolysin Prolongs Lifespan in a Mouse Model of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and LeukoencephalopathyAdvanced Biology · 2023
11. Enhanced Spontaneous Motor Recovery After Stroke in Mice Treated With CerebrolysinNeurorehabilitation and neural repair · 2021
12. C-REGS 2 - Design and methodology of a high-quality comparative effectiveness observational trialJournal of Medicine and Life · 2021
13. Phosphoproteomics of short-term hedgehog signaling in human medulloblastoma cellsCell Communication and Signaling · 2020
14. Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s DiseaseThe International Journal of Neuropsychopharmacology · 2020
15. Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head InjuryNeurorehabilitation and neural repair · 2018
16. Prospective, randomized, blinded, and placebo-controlled study of Cerebrolysin dose-response effects on long-term functional outcomes in a rat model of mild traumatic brain injuryJournal of neurosurgery · 2018
17. Effects of cerebrolysin on nerve growth factor system in the aging rat brainRestorative Neurology and Neuroscience · 2017
18. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trialsNeurological Sciences · 2017
19. A de novo compound targeting α-synuclein improves deficits in models of Parkinson’s diseaseBrain · 2016
20. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled studyInternational Journal of Stroke · 2016